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We investigated the effects of baroreceptor deﬁcit (10 weeks after sinoaortic denervation — SAD) on hemo-
dynamic alterations, cardiac and pulmonary remodeling. Cardiac function and morphology of male Wistar in-
tact rats (C) and SAD rats (SAD) (n=8/group) were assessed by echocardiography and collagen
quantiﬁcation. BP was directly recorded. Ventricular hypertrophy was quantiﬁed by the ratio of left ventric-
ular weight (LVW) and right ventricular weight (RVW) to body weight (BW). BPV was quantiﬁed in the time
and frequency domains. The atrial natriuretic peptide (ANP), alpha-skeletal actin (α-skelectal), collagen type
I and type III genes mRNA expression were evaluated by RT-PCR. SAD did not change BP, but increased BPV
(11±0.49 vs. 5±0.3 mm Hg). As expected, baroreﬂex was reduced in SAD. Pulmonary artery acceleration
time was reduced in SAD. In addition, SAD impaired diastolic function in both LV (6.8±0.26 vs. 5.02±
0.21 mm Hg) and RV (5.1±0.21 vs. 4.2±0.12 mm Hg). SAD increased LVW/BW in 9% and RVW/BW in
20%, and augmented total collagen (3.8-fold in LV, 2.7-fold in RV, and 3.35-fold in pulmonary artery). Also,
SAD increased type I (~6-fold) and III (~5-fold) collagen gene expression. Denervation increased ANP
expression in LV (75%), in RV (74%) and increased α-skelectal expression in LV (300%) and in RV (546%).
Baroreﬂex function impairment by SAD, despite not changing BP, induced important adjustments in cardiac
structure and pulmonary hypertension. These changes may indicate that isolated baroreﬂex dysfunction can
modulate target tissue damage.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Baroreceptor-mediated reﬂex control of circulation has been
found to be an important risk predictor after cardiovascular events.
Changes in baroreﬂex sensitivity and heart rate variability (HRV),
the two main markers of autonomic nervous system activity, have
been linked to an increased mortality rate, particularly in hyperten-
sive subjects with a history of cardiovascular disease (La Rovere
et al., 1998; Schwartz and La Rovere, 1998; Gerritsen et al., 2001)
Several studies have shown that reduced baroreﬂex sensitivity
and HRV are independent markers of mortality after myocardial in-
farction (La Rovere et al., 1998). Moreover, decreased baroreﬂex sen-
sitivity has been associated with increase in stroke events (Liu et al.,
2007) and atherosclerosis development (Sasaki et al., 1994). Further-
more, it can be directly associated with cardiac remodeling and dam-
age in human and animals (Grassi et al., 2006; Miao et al., 2006).
Together, these structural changes may contribute to a loss ofniversity of Sao Paulo, Medical
Subsolo, Sao Paulo, SP, Brazil,
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evier OA license.functional capacity of the heart. The hemodynamic and neurohumor-
al alterations produced by chronic sinoaortic denervation (SAD) have
been studied in rats as a model of baroreﬂex deﬁcit associated with
increased blood pressure variability (BPV) (Miao and Su, 2002;
Miao et al., 2003; Miao et al., 2004; Miao et al., 2006; Grassi et al.,
2009; Hisashi et al., 2009; Kudo et al., 2009). Indeed, SAD causes a
substantial increase in BPV with no change in the mean blood pres-
sure (BP) and it is a useful method to investigate the pathology of
high BPV. Some studies have reported that SAD produces various
forms of end-organ damage (Su and Miao, 2001), including cardiac
hypertrophy, cardiovascular remodeling, and pulmonary damage
(Miao and Su, 2002; Miao et al., 2004; Tao et al., 2008). However,
the pathogenesis of theses damages is yet to be fully understood, al-
though high BPV has been acknowledged as a major contributing
factor (Miao et al., 2006).
This lack of information on the relationship between baroreﬂex
sensitivity and myocardial structural changes and pulmonary artery
remodeling encouraged us to design the present study.
Our main objective was two-fold: a) to evaluate whether barore-
ﬂex dysfunction plays a role in the hypertrophy process within the
normal blood pressure range, and b) to evaluate whether BPV plays
a role in pulmonary hypertension.
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2.1. Animals
Experiments were performed in 2 month old male normotensive
Wistar rats, obtained from the Animal Shelter of the Biomedical Sci-
ences Institute (University of Sao Paulo, Sao Paulo, Brazil) and allocat-
ed at the Experimental Hypertension Laboratory Animal Shelter
(Heart Institute, University of Sao Paulo, Sao Paulo, Brazil). Rats
were housed in plastic cages (4 per cage) in a temperature-
controlled room (22 °C) with a 12-hour dark–light cycle receiving
standard chow and water ad libitum. All surgical procedures and pro-
tocols used were approved by the University of Sao Paulo Ethical
Committee and were in accordance with National Institutes of Health
Guide for the Care and Use of Laboratory Animals. The rats were ran-
domly assigned into 2 groups (n=8/group): normotensive control
(C) and normotensive sinoaortic denervated (SAD). After 10 weeks
all groups were submitted to hemodynamic and cardiac morphofunc-
tional evaluations.
2.2. Sinoaortic denervation
Sinoaortic denervation was performed in Wistar rats at the age of
2 months according to the procedure described by Krieger (Krieger
and Marseillan, 1963; Krieger, 1964). Brieﬂy, after a 3-cm midline inci-
sion the sternocleidomastoidmuscles were reﬂected laterally, exposing
the neurovascular sheath. The common carotid arteries and the vagal
trunk were isolated, and the aortic depressor ﬁbers, either traveling
with the sympathetic nerve or as an isolated aortic nerve, were cut.
The communicating branch of the aortic ﬁbers was also resected. The
third contingent of aortic baroreceptor ﬁbers traveling with the inferior
laryngeal nerve was interrupted by resection of the superior laryngeal
nerve after the carotid bifurcation was exposed extensively for carotid
stripping. To complete SAD, the sinus nerve, all carotid branches and
the carotid body were resected (Krieger and Marseillan, 1963).
2.3. Non-invasive evaluations of cardiac function
The transthoracic echocardiography was performed at the end of
protocol using a SEQUOIA 512 (ACUSON Corporation, Mountain View,
CA, USA). The echocardiography indexes were obtained according to
the recommendations of the American Society of Echocardiography. Im-
ages were obtained in anesthetized rats (Ketamine 80 mg/kg and Xyla-
zin 12 mg/kg, i.p.) with the transducer on each animal's shaved chest
(lateral recumbence). All measurements were based on the average of
3 consecutive cardiac cycles. Wall thickness and LV dimensions were
obtained from a short-axis view at the level of the papillary muscles.
LV mass was calculated using the following formula, assuming a spher-
ical LV geometry and already validated in rats: LV mass=0.8×{1.047
[(LVd+PWDIA+IVSDIA)3−(LVd)3]}+0.6 g, where 1.047 is the spe-
ciﬁc gravity of muscle, LVd is LV end-diastolic diameter, PWDIA is end-
diastolic posteriorwall thickness and IVSDIA is end-diastolic interventri-
cular septum thickness. In addition, another morphology index was
evaluated — the relative wall thickness (RWT), which is expressed by
2×PWDIA/LVd. This represents the relation between the LV cavity in
diastole and the LV posterior wall (Lang et al., 2005).
Parameters of systolic function: ejection fraction (EF) and velocity
of circumferential ﬁber shortening (VCF); parameters of diastolic
function: normalized LV isovolumetric relaxation time (IVRT) and
normalized peak E deceleration time (DESACE) corrected by the
square root of the R–R interval. Myocardial performance index
(MPI) was also evaluated (were quantiﬁed) (Wichi et al., 2007).
Pulmonary artery acceleration time (PAAT) was used as an echo-
cardiographic (Thibault et al., 2010) indicator of pulmonary hyper-
tension (Hardziyenka et al., 2006; Koskenvuo et al., 2010). PAAT
was measured from the onset of systolic ﬂow to peak pulmonaryoutﬂow velocity according to the American Society of Echocardiogra-
phy's Guidelines and Standards Committee and the Chamber Quanti-
ﬁcation Writing Group.
2.4. Cardiovascular and autonomic assessments
2.4.1. Hemodymamics
One day after echocardiographic evaluations, two catheters (Tygon+
PE10) were implanted in anesthetized rats (Ketamine 80 mg/kg and
Xylazin 12 mg/kg, i.p.) into the femoral artery and vein for direct mea-
surements of AP and drug administration, respectively. The catheters
were tunneled subcutaneously and exteriorized through the back of the
neck. Rats were studied 24 h after catheter placement; the ratswere con-
scious and allowed to move freely during the experiments. The arterial
cannula was connected to a strain-gauge transducer (Blood Pressure
XDCR, Kent© Scientiﬁc, Litchﬁeld, CT, USA), and AP signalswere recorded
over a 30-minute period by a microcomputer equipped with an analog-
to-digital converter board (Windaq, 2 kHz sampling frequency, Dataq In-
struments, Springﬁeld, OH,USA) (Irigoyen et al., 2005; Souza et al., 2007).
The recorded data were analyzed on a beat-to-beat basis to quantify
changes inmean AP and heart rate (HR). HR variability (HRV) and systol-
ic BPV in time domain were determined using the standard deviation of
the basal recording period.
2.4.2. Baroreﬂex sensitivity
Baroreﬂex sensitivity was evaluated by a mean index relating the
tachycardic and the bradycardic responses for mean AP changes
(~30–40 mmHg) induced by increasing doses of sodium nitroprusside
(0.05 to 1.6 μg/kg) and phenylephrine (0.25 to 32 μg/kg) injections, re-
spectively. Datawere expressed as beats perminute (bpm) permmHg.
Maximal volume per injection was 0.1 mL (Irigoyen et al., 2005; Souza
et al., 2007).
2.4.3. Invasive evaluation of cardiac function
One day after hemodynamic evaluations, two catheters (Tygon+
PE50) were implanted in anesthetized rats (pentobarbital sodium
0.1 mL/100 g, iv) into carotid artery and jugular vein and advanced
to LV and RV, respectively. Pressure signals of LV and RV were mea-
sured using a transducer (Blood Pressure XDCR, Kent© Scientiﬁc,
Litchﬁeld, CT, USA) and were digitally recorded (5 min) with a data
acquisition system (WinDaq, 2-kHz, DATAQ, Springﬁeld, OH, USA).
The recorded data were analyzed on a beat-to-beat basis to quantify
changes in LV and RV pressure. The following indices were obtained:
heart rate (HR), LV systolic pressure (LVSP), LV end-diastolic pressure
(LVEDP), and maximum rate of LV pressure rise and fall (+dP/dt
max and −dP/dt max), RV systolic pressure (RVSP), RV end-
diastolic pressure (RVEDP), and maximum rate of RV pressure rise
and fall (+dP/dt max and −dP/dt max) (Wichi et al., 2007).
2.4.4. Heart rate and blood pressure variability
Time-domain analysis consisted in calculating mean HR and sys-
tolic BP (SBP), HR variability (HRV) and SBP variability (SBPV) as
the standard deviation from its respective time series.
The overall variability of the SBPV and pulse interval was assessed
in the frequency domain analysis by spectral estimation. The whole
20-min time series of SAP and PI were cubic-spline-interpolated
(250 Hz) and decimated to be equally spaced in time. Following linear
trend removal, power spectral density was obtained by the Fast Fourier
Transformation using Welch's method over 16,384 points with a Han-
ning window and 50% overlapping. Spectral power for low-frequency
(LF: 0.20–0.75 Hz) and high-frequency (HF 0.75–3.0 Hz) bands were
calculated by power spectrum density integration within each frequen-
cy bandwidth, using a customized routine (MATLAB 6.0; Mathworks,
Natick, MA) (Bertagnolli et al., 2008; Heeren et al., 2009). The autonom-
ic balance (LF/HF) was calculated by the ratio of LF and HF absolute
values.
Table 1
Hemodynamic evaluation in normotensive control (C) and normotensive SAD (SAD)
groups.
Measurement/group C SAD
DBP (mm Hg) 89±1 92±3
SBP (mm Hg) 123±2 125±3
MBP (mm Hg) 104±2 106±3
HR (bpm) 313±6 329±3
SBP SD (mm Hg) 6±0.4 9±0.7*
TR (bpm/mm Hg) 2.92±0.14 0.46±0.07*
BR (bpm/mm Hg) 1.68±0.12 0.49±0.06*
Data are reported as mean±SEM. *pb0.05 vs. C. Results of diastolic arterial pressure
(DAP), systolic arterial pressure (SAP), mean arterial pressure (MAP), heart rate
(HR), systolic arterial pressure standard deviation (SAP SD), tachycardic (TR) and
bradycardic (BR) responses to AP changes.
Table 2
Heart rate and blood pressure variability in normotensive control (C) and normoten-
sive SAD (SAD) groups.
Measurement/group C SAD
VAR RR (ms2) 45±7.3 45±8.8
LF (ms2) 1.30±0.26 0.98±0.25
HF (ms2) 9.1±1.64 6.4±1.19
LF/HF 0.11±0.01 0.18±0.02
SBPV (mm Hg2) 10±1 57±12*
LF (mm Hg2) 1.8±0.3 4.3±0.6*
HF (mm Hg2) 1.3±0.2 1.8±0.2
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One day after cardiovascular measurements, rats were divided
into two groups. Animals were weighed and killed by decapitation.
First group: a transverse incision below the diaphragm and bilateral
thoracotomy incisions were performed in the sodium pentobarbital
(40 mg/kg i.p.) anesthetized rats, in order to expose the heart. A needle
(40×12) was carefully introduced into the LV apex. The heart was
arrested in diastole by perfusion with a NaCl 0.9% plus 14 mMKCl solu-
tion (pressure equal to a 9.56 mmHg), followed by 10% formaldehyde
for tissue ﬁxation. Brieﬂy, hearts and lungs were excised, trimmed,
weighed and immersed in formaldehyde 4% in PBS for 24 h. Following
this, LV, RV and lung were transected perpendicular to the long axis
and processed and embedded in parafﬁn to perform histological sec-
tions. Histomorphometric analyses were performed by blinded ob-
servers. Sections of 5μm-think were stained with picrosirius red for
collagen quantiﬁcation (Junqueira, 1979; Piratello et al., 2010). Mor-
phometric data were obtained from histological images made in light
microscope (Leica DMR; LeicaMicrosystemsGmbH,Wetzlar, Germany)
connected to a video camera coupled to a compatible microcomputer.
The images were processed using the Image-Pro Plus 6.0 for windows
software (Media Cybernetics, USA). All measures were performed in
histological images obtained with the 40× objective lens.
Second group: Hearts were dissected into bilateral ventricles and
weighed. The ratio of left and right ventricular weight (mg) to body
weight (g) was evaluated as an index of ventricular hypertrophy.
Ventricles were kept at −80 °C, and used for PCR assay.Alpha índex (ms/mm Hg) 0.91±0.04 0.51±0.10*
Data are reported as mean±SEM. *pb0.05 vs. C. Results of spectral powers of RR
interval variability (VAR RR), low frequency (LF: 0.20–.75 Hz), high frequency (HF:
0.75–3.00 Hz) bands, autonomic balance (LF/HF), and systolic blood pressure
variability (SBPV).2.4.6. Real-time RT-PCR
Total RNA was obtained using the Trizol reagent (Invitrogen), fol-
lowing the manufacturer instructions. For reverse transcriptase, we
employed 1 μg of total RNA using SuperScript II RNase H Reverse
Transcriptase (Invitrogen). Real-time RT-PCR was performed using
the SYBR Green PCR master mix (Invitrogen) in a thermocycler,
according to manufacturer recommendations (Corbett Research, Syd-
ney, Australia). The following primer sequences were used:
– for β-actin: 5 -AGT TCG CCA TGG ATG ACG AT-3 and 5 -AAG CCG
GCC TTG CAC AT-3
– for atrial natriuretic factor (ANF): 5 -AGT GCG GTG TCC AAC ACA
G-3 and 5 -CTT CAT CGG TCT GCT CGC T-3
– for skeletal α-actin: 5 -CCT GCC ACA CGC CAT CAT-3 and 5 -GCT
CGG TGA GGA TTT TCA TCA G-3
– collagen type I: 5 -CGA GAC CCT TCT CAC TCC TG-3
5 -GCA TCC TTG GTT AGG GTC AA-3
– collagen type III: 5 -TGG TTT CTT CTC ACC CTG CT-3
5 -TCT CCA AAT GGG ATC TCT GG-3 .
Samples were run in duplicate, and the real-time RT-PCR data
were normalized to β-actin gene.Table 3
Echocardiograph morphometric parameters in normotensive control (C) and normo-
tensive SAD (SAD) groups.2.4.7. Statistical analysis
Data are reported as mean±SEM and Student's t test was used to
compare means between the two groups. Pearson correlation was
used to study the association between variables. The signiﬁcance
level was established as pb0.05.Measurement/group C SAD
LVDIA/BW (cm/g) 1.86±0.05 1.72±0.04
IVSDIA/BW (cm/g) 0.30±0.01 0.33±0.02
LVPWDIA/BW (cm/g) 0.30±0.01 0.37±0.01*
RWT (cm) 0.32±0.01 0.41±0.03*
LV mass/BW (mg/g) 3.53±0.09 3.66±0.15*
Data are reported as mean±SEM. *pb0.05 vs. C. Results of LVDIA, left ventricular
diastolic dimension; IVSDIA, diastolic interventricular septum; LVPWDIA, diastolic
left ventricular posterior wall thickness; RWT, relative wall thickness; LV mass/BW,
left ventricular mass; BW, body weight.3. Results
3.1. Body weight
Body weight was not different between groups at the beginning
(two weeks: C: 223±4 vs. SAD: 223±4 g) and at the end of the pro-
tocol (10 weeks: C: 423±8 vs. SAD: 421±8 g).3.2. Hemodynamic assessments
As shown in Table 1, SAD did not change BP values. However, SAD
increased the systolic BPV, as expressed by standard deviation and
total variance. Baroreﬂex sensitivity, as expected, was reduced in
SAD group. Both bradycardic and tachycardic responses were reduced
in SAD group (Table 1).
3.3. Heart rate and blood pressure variability
The variability of SBP in the time domain and LF of BP were in-
creased in denervated animals. As expected, the alpha index was re-
duced in SAD group (Table 2).
Despite the tendency towards decreasing values of LF and HF of
HRV in SAD group, there were no differences when compared with
intact group. In fact, these results were reﬂected in no change in auto-
nomic balance (LF/HF) (Table 2).
3.4. Non-invasive evaluation of cardiac function
Echocardiographic evaluations, performed 10 weeks after SAD,
were shown in Tables 3 and 4.
Table 4
Pulmonary artery acceleration time (PAAT) and echocardiograph left ventricular func-
tional parameters in normotensive control (C) and normotensive SAD (SAD) groups.
Measurement/group C SAD
PAAT (ms) 40±1.3 33±1.0*
MPI 0.36±0.012 0.51±0.025*
Systolic function
EF (%) 0.72±0.08 0.63±0.01*
VCF (circ/s) 0.0048±0.0002 0.0058±0.0004*
Diastolic function
nIVRT (ms) 1.47±0.034 1.93±0.088*
nDESACE (ms) 2.28±0.07 2.85±0.19*
Data are reported as mean±SEM. *pb0.05 vs. C. Results of MPI, myocardial
performance index; EF, ejection fraction; VCF, velocity of circumferential ﬁber
shortening; nIVRT, normalized isovolumetric relaxation time; nDESACE, normalized
Peak E deceleration time.
Table 5
Invasive evaluations of left ventricular function in normotensive control (C) and nor-
motensive SAD (SAD) groups.
Measurement/group C SAD
LVEDP (mm Hg) 5.02±0.21 6.8±0.26*
LV+dP/dt max (mm Hg/s) 5807±399 4404±206*
LV−dP/dt max (mm Hg/s) –3796±365 –2793±201*
RVEDP (mm Hg) 4.2±0.12 5.1±0.21*
RV+dP/dt max (mm Hg/s) 1253±76 1574±166
RV−dP/dt max (mm Hg/s) –927±83 –1232±73
Data are reported asmean±SEM. *pb0.05 vs. C. Results of LVEDP, left ventricle end-diastolic
pressure; LV+dP/dt max, maximum rate of left ventricle pressure rise; LV−dP/dt max,
maximum rate of left ventricle pressure fall; RVEDP, right ventricle end-diastolic pressure;
RV+dP/dt max, maximum rate of right ventricle pressure rise; RV−dP/dt max,
maximum rate of right ventricle pressure fall.
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VCF and EF parameters. Moreover, SAD presented LV diastolic dys-
function as indicated by IVRT and DESACE. Additionally, SAD pre-
sented elevated MPI compared to intact rats.Fig. 1. (A) Collagen type I gene expression in the left ventricle, (B) collagen type I gene expre
(D) collagen type III gene expression in the right ventricle in control (C) and SAD (SAD) grThe parameter of PAAT was reduced in SAD group, indicating pul-
monary hypertension in this group (Table 3).
3.5. Invasive evaluation of cardiac function
Invasive measurements of cardiac function by LV catheterization,
demonstrated diastolic impairment in SAD rats. EDP, an index of conges-
tive heart failure, showed a signiﬁcant increase in SAD rats compared
with intact rats. The LV+dP/dt and LV−dP/dt max were impaired in
SAD rats (Table 5).
Similarly, an impairment of RVEDP was observed in SAD rats.
However, no differences were observed in RV− or +dP/dt (Table 4).
3.6. Cardiac morphometry
SAD induced LV hypertrophy, as indicated by LV/BW estimated
mass by echocardiography in SAD animals (Table 3).
Echocardiographic evaluation showed that there were no differ-
ences in both LV internal dimension (cm) during diastole and thick-
ness of interventricular septum between the two groups. However,
during diastole, the posterior wall was higher in the SAD group than
in the control group. In addition, the LV relative wall thickness was in-
creased in SAD (Table 3).
SAD induced LV and RV hypertrophy, according to LVW/BW and
RVW/BW index (LV: 2.35±0.08, vs. 2.15±0.02 and RV: 0.6±0.03
vs. 0.5±0.01 mg/g, respectively).
SAD induced an augment in LV and in RV collagen in SAD in relation
to C rats (LV: 0.0767±0.009 vs. 0.02±0.01% and RV: 0.046±0.006 vs.
0.017±0.01%, respectively) (Figs. 3 and 4).
3.7. Real-time RT-PCR
Collagen gene expression types I and III were markedly augmented
in LV in SAD rats when compared to control rats (type I: 6.81±0.13
vs. 1.01±0.09 and type III: 5.68±0.47 vs. 0.99±0.04 fold of induction,
respectively). Similar results were observed in RV (type I: 3.23±0.06ssion in the right ventricle, (C) collagen type III gene expression in the left ventricle, and
oups.
Fig. 2. (A) α-skelectal actin gene expression in the left ventricle, (B) α-skelectal actin gene expression in the right ventricle, (C) atrial natriuretic factor (ANF) gene expression in the
left ventricle, and (D) atrial natriuretic factor (ANF) gene expression in the right ventricle in control (C) and SAD (SAD) groups.
51K. Flues et al. / Autonomic Neuroscience: Basic and Clinical 166 (2012) 47–53vs. 0.99±0.02 and type III: 4.56±0.24 vs. 1.01±0.1 fold of induction,
respectively) (Fig. 1A, B, C, and D).
SAD enhanced atrial natriuretic factor (ANF) gene expression andα-
skelectal actin gene expression in LV as compared to intact rats (ANF:
1.83±0.21 vs. 1.04±0.06 and α-skelectal actin gene: 3.35±0.52
vs. 0.89±0.10, fold of induction, respectively) (Fig. 2C and A). A sim-
ilar increase was observed in RV (ANF: 1.55±0.24 vs 0.89±0.129
and α-skelectal actin gene: 6.4±0.24 vs. 0.99±0.38, fold of induc-
tion, respectively) (Fig. 2B and D).
Correlation analysis involving all studied animals showed a signif-
icant positive relationship between BPV and ANF (r2=0.72,
pb0.031); BPV and collagen type I (r2=0.86, pb0.007); BPV and col-
lagen type III (r2=0.62, pb0.019).
3.8. Collagen volume fraction evaluation in pulmonary artery
The collagen content of the medial layer of intra-acinar arteries
was measured. SAD rats presented increased percentage of collagen
in pulmonary artery when compared to control rats (8.85±0.99 vs.
2.64±0.050%).Fig. 3. Photomicrography of collagen ﬁbers in the lef4. Discussion
Cardiac hypertrophy is a common feature of cardiovascular diseases.
Clinical and experimental studies have demonstrated that high blood
pressure is a major determinant of cardiac hypertrophy in hyperten-
sion; however, several other factors contribute to the remodeling pro-
cess. On the other hand, a study from Miao et al. has suggested that
blood pressure variability is more important in the determination of
end-organ damage than blood pressure levels (Miao et al., 2006). In
the present study, our results demonstrated that baroreﬂex dysfunction
(and the resulting changes in BPV) plays an important crucial role in the
cardiac remodeling process, since denervated animals presented in-
creased LV/BW index but similar BP levels when compared to their in-
tact controls. The results of this study strongly suggest that, regardless
of changes in BP levels, the isolated deafferentation of the baroreceptors
was able to provoke cardiac hypertrophy.
SADmodels are characterized by the interruption of carotid and aor-
tic baroreceptors afferents, resulting in baroreﬂex dysfunction. It is
worth stressing that the SAD procedure included denervation of the ca-
rotid chemoreceptors. In some studies, chemoreceptor denervation hast ventricle in control (C) and SAD (SAD) groups.
Fig. 4. Photomicrography of collagen ﬁbers in the right ventricle in control (C) and SAD (SAD) groups.
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cardiac hypertrophy (Franchini et al., 1994 and Van Vliet et al., 1999).
In the study of VanVliet et al., 1999 a complete denervation of the carot-
id region alonewas sufﬁcient to cause the cardiac hypertrophy,whereas
the heart was unaffected by carotid denervation that spared the carotid
chemoreceptors. Thus, it is possible that chemoreceptor denervation
contributed to cardiac changes; however, this very same study reported
that right ventricle hypertrophywasmostly inﬂuenced by chemorecep-
tor denervation, whereas left ventricle hypertrophy may have been a
consequence of baroreﬂex impairment.
In this study we observed few changes in the right cardiac func-
tion, but the normotensive animals submitted to SAD were followed
just for ten weeks. In longer periods of observation they might pre-
sent additional changes, since the removal of the carotid body and
the interruption of the laryngeal nerve represent a chronic carotid de-
nervation procedure (O`Leary et al., 2004).
The factors inﬂuencing the cardiac hypertrophy process above dis-
cussedwere quantitatively analyzed in the two groups studied: normo-
tensive (C) and normotensive denervated (SAD) rats. Interestingly,
denervation induced an increased index of hypertrophy in both LV/
BW ratio and RV/BW ratio in SAD, accompanied by an increased colla-
gen deposition when compared to intact normotensive group, indicat-
ing that denervation, solely, produced the observed structural changes.
These ﬁndings were conﬁrmed by echocardiography data, as
shown by the estimated ventricular mass, posterior wall thickness
during diastole and the relative wall thickness, which is regarded as
the best indicator of the remodeling process.
Which mechanisms involved in cardiac adjustments would ac-
count for the abolishment of baroreceptor function? It is well
known that sinoaortic denervation increases BPV and that this is an
important contributing factor to end-organ damage (Miao and Su,
2002; Agabiti-Rosei et al., 2007). Indeed, changes in heart structure
have been described after performing SAD in rats. Miao and Su have
described left ventricular hypertrophy in 10–16 weeks, but not in
2 weeks, and have shown that in SAD rats hypertrophy was both sig-
niﬁcantly and positively related with BPV, but not with BP level (Judy
and Farrell, 1979). These data lend support to the results we obtained
after 10 weeks of SAD and indicate that denervation-induced cardiac
hypertrophy is a time dependent process. However, it is important to
highlight that Miao and Su (2002) have found high mortality (40%)
after SAD as well as a reduction of BPV during the SAD time course.
In the present study, denervated animals did not die in consequence
of baroreﬂex abolishment (data not shown).
On the other hand, cardiac functional analysis carried out through
invasive and non-invasive evaluations demonstrated a sharp diastolic
dysfunction and a mild systolic dysfunction in SAD rats. These results
were demonstrated by enhanced end-diastolic pressure in both LVand RV resulting in a decrease in EF, increase in VCF, IVRT, nDESACE
and, consequently, enhanced MPI. Although alterations in systolic
function have been observed, we should emphasize that this change
cannot be seen as a marker of severe systolic dysfunction, since the
change we observed in this parameter was rather mild.
Furthermore, HRV and LF andHF components of HRVwere similar in
both groups, while the sympathetic modulation of BP (LF SBP) was in-
creased in SAD animals. This is an important ﬁnding, since it points to
another important lesion mechanism associated with SAD. In fact, the
sympathetic system over activity has been repeatedly demonstrated in
hypertension (Judy and Farrell, 1979). Moreover, sympathetic activity
has been associated with end-organ damage and heart failure (Irigoyen
et al., 1995; Brum et al., 2000; Malliani andMontano, 2002). During car-
diac hypertrophy there is a cardiac myocyte gene reexpression which is
expressed only during the early stages of development. This fetal repro-
gramming includes the reexpression of genes in ventricules, such as
ANF, α-skeletal actin, and ß-myosin heavy chain. The reexpression of
these fetally expressed genes is a well documented marker of a patho-
logical cardiac hypertrophy in normal aging in many experimental
models (Vikstrom et al., 1998).
The analysis of ANF, alpha-skeletal actin and collagen types I and
III gene expression, is an important marker of hypertrophy and ﬁbro-
sis development which may reinforce our data interpretation and the
discussion carried out above. The positive and signiﬁcant relation-
ships between BPV and ANF (r2=0.72, pb0.031); BPV and collagen
type I (r2=0.86, pb0.007); BPV and collagen type III (r2=0.62,
pb0.019) reinforce this possibility.
Indeed, these results show that isolated baroreceptor denervation
was able to induce cardiac hypertrophy in normotensive animals.
Morphometric data were accompanied by an expression increase of
those hypertrophy gene markers in LV and RV in SAD animals, signal-
ing the hypertrophic stimulus.
Cardiac hypertrophy occurs as a response to a sequence of
changes, including initiating signals, biochemical adjustments and
regulation of gene expression. This study showed that arterial reﬂex
dysfunction represents not only a marker of cardiovascular disease
but also contributes to the progression of the disease, regardless of
the ﬁnal blood pressure level.
Another importantﬁnding of this study is that SAD animals presented
reduced PAAT and increased RVEDP as demonstrated by non-invasive
and invasive evaluations, respectively. To corroborate this ﬁnding, a
signiﬁcant and positive correlation between PAAT and RVEDP was
found in all studied animals (r2=0.61, pb0.044); data not shown.
Additionally, SAD also presented a remodeling of the pulmonary
artery wall as demonstrated by collagen deposition. All these ﬁndings
suggest that the isolated baroreceptor denervation was able to induce
pulmonary hypertension.
53K. Flues et al. / Autonomic Neuroscience: Basic and Clinical 166 (2012) 47–53Pulmonary artery remodeling has been found to be one of the lead-
ing causes of increase in pulmonary artery pressure (Xie et al., 2010).
In conclusion, baroreﬂex dysfunction induces adjustments in cardio-
vascular structure, morphometry, genetic, hemodynamics and auto-
nomic proﬁle and produces alterations in pulmonary pressure. These
ﬁndings may provide an opportunity to include new strategies to im-
prove baroreﬂex function and to reduce BPV in the therapeuticmanage-
ment of the target organ in cardiovascular pulmonary diseases.
4.1. Perspectives
Baroreﬂex dysfunction has already been highlighted as an impor-
tant prognostic marker in a range of cardiovascular conditions. Our
study reinforces its importance in mediating the cardiac hypertrophy
process in normotensive conditions and shed a light on the mecha-
nisms which may be involved in the cardiac damage caused by baror-
eﬂex impairment. The observations presented in this investigation
open a fruitful area for further studies regarding possible interven-
tions which should consider the restoration of baroreﬂex sensitivity
to normal values, in order to prevent the associated derangements.
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